Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687529 · ClinicalTrials.gov registry record
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
A clinical trial, sponsored by QIAGEN Gaithersburg.
- Completed
- Registry status
- 66
- Enrollment target
NCT02687529 is a clinical trial that has completed, run by QIAGEN Gaithersburg. The registered enrollment target is 66 participants.
The verdict
NCT02687529 has completed, sponsored by QIAGEN Gaithersburg.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.
Interventions
- DEVICE CST001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2015-10-27 |
| Est. Completion | 2016-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02687529
The ClinicalTrials.gov registry entry for NCT02687529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QIAGEN Gaithersburg, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CST001 is the first listed.
NCT02687529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02687529 about?
NCT02687529 is a clinical study titled "Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection". To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.
What is the current status of trial NCT02687529?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2015-10-27. Estimated completion is 2016-05-26.
What interventions are being tested in trial NCT02687529?
The interventions under investigation include: CST001 (DEVICE).
Who is sponsoring clinical trial NCT02687529?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.